<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A retrospective study of 26 quinacrine-treated <z:e sem="disease" ids="C0409974" disease_type="Disease or Syndrome" abbrv="">lupus erythematosus</z:e> patients failed to show evidence of drug-induced ocular changes </plain></SENT>
<SENT sid="1" pm="."><plain>Although <z:chebi fb="1" ids="8711">quinacrine</z:chebi> commonly produces minor side effects, such as yellow discoloration of the skin, and may rarely produce very serious side effects, such as <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, it appears to produce much less oculotoxicity than does <z:chebi fb="3" ids="3638">chloroquine</z:chebi> </plain></SENT>
</text></document>